The domestic launch of the new epilepsy drug, ‘Fycompa’ came close

The domestic launch of a new epilepsy drug is approaching.

The Ministry of Food and Drug Safety approved commercialization of the Eisai’s anti-epilepsy drug, ‘Fycompa(perampanel)’ on the 10^th.

Fycompa were approved in 6 types of volume, such as 2mg, 4mg, 6mg, 8mg and 10mg, and has acquired 6 years of the re-deliberation period.

In regards of indication, the drug is approved to be used as the...